Tenon Medical financials
$2.73−4.55%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $3.9M | $3.3M | $2.9M | $691.0K |
| Gross profit | $2.4M | $1.7M | $1.2M | -$641.0K |
| Gross margin | 59.8% | 52.2% | 42.4% | −92.8% |
| Operating income | -$12.8M | -$13.8M | -$15.7M | -$18.7M |
| Net income | -$12.6M | -$13.7M | -$15.6M | -$18.9M |
| Net margin | −318.4% | −417.2% | −532.1% | −2737.6% |
| Diluted EPS | $-59.50 | $-394.10 | $-2402.40 | $-6613.60 |
| EBITDA | -$12.5M | -$13.4M | -$15.5M | -$18.6M |
| Operating cash flow | -$10.7M | -$9.9M | -$12.2M | -$12.0M |
| Free cash flow | -$11.8M | -$10.1M | -$12.5M | -$12.9M |
| Diluted shares | 0.2M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $3.8M | $6.5M | $2.4M | $2.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $6.4M |
| Total debt | $0.00 | $0.00 | $1.2M | $0.00 |
| Total assets | $10.8M | $9.8M | $6.3M | $11.1M |
| Total liabilities | $5.7M | $3.9M | $5.6M | $4.8M |
| Shareholders' equity | $5.0M | $6.0M | $778.0K | $6.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology